Argenica Therapeutics LtdASX: AGN

Phase 1 Clinical Trial Progress Update

Nov 25, 2022 at 2:41 AM UTC · Issued by Argenica Therapeutics Ltd

Argenica Therapeutics Ltd has released a press release.

View Attachment